Memantine oral dosage forms

Details for Australian Patent Application No. 2004249151 (hide)

Owner Allergan, Inc.

Inventors Cheetham, Janet K.; Espiritu, J. Abraham M.; Firestone, Bruce A.; Vander Zanden, John J.; Kurjan, Richard; Kuan, Teresa H.; Chang, Chin-Ming

Agent Davies Collison Cave

Pub. Number AU-A-2004249151

PCT Pub. Number WO2004/112768

Priority 60/478,979 16.06.03 US

Filing date 10 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/112768 Priority application(s): WO2004/112768

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249155-Monitoring immunologic, hematologic and inflammatory diseases

2004249146-Non-invasive measurement of blood glucose